Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.11/Share
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $1.18 -2.48%
Financial Fact:
OPERATING LOSS: -6.65M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Financial Fact:
OPERATING LOSS: -6.65M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.11), versus ($0.05) reported last year. Revenue for the quarter came in at $1.77 million, versus $1.34 million reported last year.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
- Morphic Holding, Inc. (MORF) Tops Q1 EPS by 6c
- FTI Consulting (FCN) Tops Q1 EPS by 40c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
